Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Positive Regulator Molecules

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.

Positive Regulator Molecules

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Inhibition of CDK Activity

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

M-Cdk Drives Transition Into Mitosis

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

The Cell Cycle Control System

The Cell Cycle Control System

The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Stem-Cell Niches in Health and Disease: Microenvironmental Determinants of Regeneration and Pathology.

Cells·2025

Same author

Special Issue "Functional Role of Cytokines in Cancer and Chronic Inflammation".

International journal of molecular sciences·2025

Same author

ANGIOTENSIN II FOR CATECHOLAMINE-RESISTANT VASODILATORY SHOCK IN PATIENTS WITH ACUTE KIDNEY INJURY: A POST HOC ANALYSIS OF THE ATHOS-3 TRIAL.

Shock (Augusta, Ga.)·2024

Same author

Cytokine Profiling of Plasma and Atherosclerotic Plaques in Patients Undergoing Carotid Endarterectomy.

International journal of molecular sciences·2024

Same author

Morphological and cytoskeleton changes in cells after EMT.

Scientific reports·2023

Same author

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study.

Annals of the rheumatic diseases·2022

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

Cyclin D1 expression in B-cell lymphomas.

Aleena Gladkikh¹, Daria Potashnikova, Elena Korneva

¹Laboratory of Functional Morphology of Hematoblastoses, National Research Center for Hematology, Moscow, Russia. aleena_gladkikh@mail.ru

Experimental Hematology

|August 24, 2010

Summary

Cyclin D1 is significantly elevated in most B-cell lymphomas, especially mantle cell lymphoma. This suggests multiple pathways contribute to cyclin D1 upregulation in malignant B cells.

More Related Videos

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Analysis of Cell Cycle Position in Mammalian Cells

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Related Experiment Videos

Last Updated: Jun 10, 2026

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Analysis of Cell Cycle Position in Mammalian Cells

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Area of Science:

Hematology
Oncology
Molecular Biology

Background:

Cyclin D1 is a key cell cycle regulator with oncogenic potential.
Normal mature B lymphocytes express low levels of cyclin D1.
Elevated cyclin D1 is observed in various B-cell malignancies.

Purpose of the Study:

To quantify cyclin D1 expression in different types of B-cell lymphomas.
To compare cyclin D1 levels between lymphomas and normal B cells.

Main Methods:

Real-time quantitative polymerase chain reaction (RT-qPCR) was used to measure cyclin D1 mRNA levels.
Cyclin D1 expression was normalized using three stable reference genes (YWHAZ, ubiquitin c, HPRT).
Five B-cell lymphoma subtypes were analyzed: mantle cell lymphoma, B-cell chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma.

Main Results:

Mantle cell lymphoma showed a four-order-of-magnitude increase in cyclin D1 expression compared to normal lymphocytes.
Other B-cell lymphomas also exhibited significantly elevated cyclin D1 levels (e.g., two orders for B-cell chronic lymphocytic leukemia).
Cyclin D1 levels were significantly higher in all tested lymphomas than in reactive lymphoid tissue and sorted normal B cells.

Conclusions:

Mantle cell lymphoma, characterized by t(11;14) translocation, has markedly elevated cyclin D1.
B-cell lymphomas lacking t(11;14) also show significant cyclin D1 upregulation.
These findings suggest diverse mechanisms for cyclin D1 overexpression in malignant B cells.